Sientra (NASDAQ:SIEN) Downgraded by StockNews.com

StockNews.com cut shares of Sientra (NASDAQ:SIEN) from a hold rating to a sell rating in a research report sent to investors on Thursday morning.

Separately, Craig Hallum reiterated a hold rating on shares of Sientra in a report on Tuesday, October 31st.

Sientra Stock Performance

Shares of NASDAQ:SIEN opened at $0.80 on Thursday. The firm has a market cap of $9.57 million, a PE ratio of -0.14 and a beta of 1.92. The firm’s fifty day moving average is $1.77 and its 200-day moving average is $2.33. Sientra has a 52 week low of $0.59 and a 52 week high of $4.94.

Hedge Funds Weigh In On Sientra

Hedge funds and other institutional investors have recently bought and sold shares of the company. Mirabella Financial Services LLP acquired a new position in Sientra in the first quarter valued at $26,000. Advisor Group Holdings Inc. lifted its holdings in Sientra by 230.9% in the first quarter. Advisor Group Holdings Inc. now owns 11,930 shares of the medical instruments supplier’s stock valued at $26,000 after buying an additional 8,325 shares during the period. LPL Financial LLC acquired a new position in Sientra in the second quarter valued at $31,000. Wolverine Trading LLC acquired a new position in Sientra in the second quarter valued at $32,000. Finally, Virtu Financial LLC acquired a new position in Sientra in the second quarter valued at $32,000. Institutional investors and hedge funds own 15.38% of the company’s stock.

About Sientra

Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.